Efficacy and safety of coadministration of sitagliptin with insulin glargine in type 2 diabetes
Author:
Affiliation:
1. Department of Endocrinology, Nanfang Hospital; Southern Medical University; Guangzhou China
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12436/fullpdf
Reference20 articles.
1. Status of blood glucose control and treatment of type 2 diabetes in China;Ji;Chin J Diabetes Mellit,2012
2. 7. Approaches to glycemic treatment;American Diabetes Association (ADA);Diabetes Care,2015
3. Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: The open-label, randomized GALAPAGOS study;Aschner;J Diabetes Complications,2015
4. Efficacy and safety of sitagliptin add-on therapy in Japanese patients with type 2 diabetes on insulin monotherapy;Kadowaki;Diabetol Int,2013
5. Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes;Vilsbøll;Diabetes Obes Metab,2010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus;Diabetes Therapy;2022-06-30
2. Efficacy and safety of DPP‐IV inhibitors combined with basal insulin in the treatment of type 2 diabetes;Journal of Diabetes;2020-10-24
3. Effect of Dipeptidyl Peptidase 4 Inhibitors Used in Combination with Insulin Treatment in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis;Diabetes Therapy;2020-09-02
4. Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V);Advances in Therapy;2020-03-04
5. Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2019-08
Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3